- Home
- TCRX vs NCTY Comparison
TCRX vs NCTY Comparison
Compare TCRX & NCTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- NCTY
- Stock Information
- Founded
- TCRX 2018
- NCTY 1999
- Country
- TCRX United States
- NCTY China
- Employees
- TCRX N/A
- NCTY N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- NCTY Business Services
- Sector
- TCRX Health Care
- NCTY Consumer Discretionary
- Exchange
- TCRX Nasdaq
- NCTY Nasdaq
- Market Cap
- TCRX 140.7M
- NCTY 121.2M
- IPO Year
- TCRX 2021
- NCTY 2004
- Fundamental
- Price
- TCRX $1.92
- NCTY $9.38
- Analyst Decision
- TCRX Strong Buy
- NCTY
- Analyst Count
- TCRX 5
- NCTY 0
- Target Price
- TCRX $9.40
- NCTY N/A
- AVG Volume (30 Days)
- TCRX 648.1K
- NCTY 124.2K
- Earning Date
- TCRX 11-07-2025
- NCTY 01-01-0001
- Dividend Yield
- TCRX N/A
- NCTY N/A
- EPS Growth
- TCRX N/A
- NCTY N/A
- EPS
- TCRX N/A
- NCTY N/A
- Revenue
- TCRX $6,961,000.00
- NCTY $15,305,175.00
- Revenue This Year
- TCRX $255.18
- NCTY N/A
- Revenue Next Year
- TCRX N/A
- NCTY N/A
- P/E Ratio
- TCRX N/A
- NCTY N/A
- Revenue Growth
- TCRX N/A
- NCTY N/A
- 52 Week Low
- TCRX $1.02
- NCTY $7.07
- 52 Week High
- TCRX $6.23
- NCTY $20.59
- Technical
- Relative Strength Index (RSI)
- TCRX 41.52
- NCTY 46.77
- Support Level
- TCRX $2.23
- NCTY $8.62
- Resistance Level
- TCRX $2.43
- NCTY $10.54
- Average True Range (ATR)
- TCRX 0.19
- NCTY 0.75
- MACD
- TCRX -0.04
- NCTY 0.00
- Stochastic Oscillator
- TCRX 1.52
- NCTY 32.47
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About NCTY The9 Limited American Depository Shares
The9 Ltd operates a cryptocurrency mining business. It provides computing power, or hash rate, to a Bitcoin mining pool and is entitled to receive a fractional share of Bitcoin award from the Bitcoin mining pool in return. The company generates its revenues from customers in Greater China, Asia/Eastern Europe, and North America. Its segments are: Crypto mining business, and Other, out of which Crypto mining business derives maximum revenue.